Abstract
Adverse drug reactions (ADRs) are a common consequence of medications, with an estimated 10-20% of all hospitalised patients experiencing a drug side effect1-2; those affecting the skin being the most frequently recorded. The need to optimise management of cutaneous ADRs has been underlined by the recent publication of NICE Guidelines on Drug Allergy3, setting out a range of standards to enhance the diagnosis and management of patients developing allergic reactions to drugs. This study was undertaken to assess the number of drug allergy referrals, and the types of cutaneous drug reaction encountered in the in-patient population.
This article is protected by copyright. All rights reserved.
http://ift.tt/2m5Aai8
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου